Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
34 participants
OBSERVATIONAL
2024-01-22
2025-05-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Symptom information and cycle length will also be recorded to observe how these change through the menopause transition.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Menopause Sample Collection
NCT04853472
Diet, Cardiometabolic Risk (CM) and Menopause Symptoms
NCT05764473
Symptom Monitoring and Menopausal Symptoms
NCT05603234
The Menopause After Cancer Study
NCT04766229
Metabotyping in the Postmenopausal Stage
NCT05397015
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Three sets of 10 consecutive daily urine samples will be collected at three timepoints (month 0, month 6 and month 12).
Urine samples will be received in the clinical laboratory and aliquoted into 2.25ml amounts and stored at -80˚C until required.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Use of hormone replacement therapy (HRT)
* Use of hormone contraception
* Hysterectomy and/or oophorectomy
* Pregnant or breast feeding
* Other medical reason for amenorrhea (absence of menstruation)
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SPD Development Company Limited
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Raniero Zazzeroni
Role: STUDY_DIRECTOR
SPD Development Company
Jackie Boxer
Role: PRINCIPAL_INVESTIGATOR
SPD Development Company
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SPD Development Company Ltd
Bedford, Bedfordshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PROTOCOL-1415
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.